Charles River Laboratories International Accounts Payables 2011-2026 | CRL

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
149 M	140 M	169 M	206 M	198 M	122 M	111 M	66.2 M	77.8 M	68.5 M	36.7 M	33.8 M	31.8 M	31.2 M	34.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
206 M	31.2 M	98.4 M

Quarterly Accounts Payables Charles River Laboratories International

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
170 M	146 M	149 M	140 M	136 M	133 M	-	169 M	136 M	140 M	120 M	206 M	182 M	-	226 M	198 M	128 M	111 M	127 M	122 M	122 M	122 M	122 M	111 M	111 M	111 M	111 M	66.2 M	66.2 M	66.2 M	66.2 M	77.8 M	77.8 M	77.8 M	77.8 M	68.5 M	68.5 M	68.5 M	68.5 M	36.7 M	36.7 M	36.7 M	36.7 M	33.8 M	33.8 M	33.8 M	33.8 M	31.8 M	31.8 M	31.8 M	31.8 M	31.2 M	31.2 M	31.2 M	31.2 M	34.3 M	34.3 M	34.3 M	34.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
226 M	31.2 M	89 M

Accounts Payables of other stocks in the Diagnostics research industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Agilent Technologies A	446 M	$ 110.24	-2.87 %	$ 33.5 B	USA
Enzo Biochem ENZ	1.38 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	176 M	-	-	$ 19.8 B	USA
Akumin AKU	36.6 M	-	-17.87 %	$ 25.9 M	Canada
Biodesix BDSX	2.19 M	$ 14.21	-2.67 %	$ 1.84 B	USA
Biomerica BMRA	295 K	$ 2.01	-4.74 %	$ 4.62 M	USA
Burning Rock Biotech Limited BNR	63.1 M	$ 16.36	-11.57 %	$ 176 M	China
Sotera Health Company SHC	78 M	$ 13.13	-3.03 %	$ 3.73 B	USA
Celcuity CELC	6.41 M	$ 106.02	-7.66 %	$ 4.96 B	USA
Check-Cap Ltd. CHEK	952 K	-	-	$ 9.42 M	Israel
DarioHealth Corp. DRIO	2.93 M	$ 8.11	-4.02 %	$ 32.3 M	Israel
Heska Corporation HSKA	16.4 M	-	-	$ 1.31 B	USA
BioNano Genomics BNGO	5.59 M	$ 1.16	0.87 %	$ 6.32 M	USA
DermTech DMTK	1.48 M	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	881 K	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	344 M	$ 62.25	-5.81 %	$ 24.3 B	USA
Accelerate Diagnostics AXDX	4.5 M	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	8.33 M	-	-	$ 399 M	China
HTG Molecular Diagnostics HTGM	1.16 M	-	-20.0 %	$ 1.06 M	USA
Castle Biosciences CSTL	6.9 M	$ 23.53	-4.74 %	$ 654 M	USA
Quest Diagnostics Incorporated DGX	307 M	$ 195.51	-1.22 %	$ 21.7 B	USA
Organovo Holdings ONVO	1.64 M	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	245 K	-	-16.95 %	$ 1.54 M	USA
Guardant Health GH	54.4 M	$ 84.61	-3.96 %	$ 10.6 B	USA
Biocept BIOC	1.52 M	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	173 M	$ 102.08	-0.97 %	$ 8.42 B	Irlanda
IDEXX Laboratories IDXX	110 M	$ 558.32	-2.61 %	$ 44.9 B	USA
Illumina ILMN	221 M	$ 117.67	-5.41 %	$ 18.7 B	USA
PerkinElmer PKI	185 M	-	-0.91 %	$ 14.7 B	USA
Invitae Corporation NVTA	14 M	-	-	$ 21.2 M	USA
IQVIA Holdings IQV	322 M	$ 163.85	-3.28 %	$ 28.2 B	USA
Interpace Biosciences IDXG	1.66 M	$ 1.68	-2.89 %	$ 7.37 M	USA
QIAGEN N.V. QGEN	83.3 M	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	79.6 M	$ 8.7	-4.92 %	$ 1.89 B	USA
Chembio Diagnostics CEMI	3.34 M	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	841 M	$ 264.2	-1.56 %	$ 22 B	USA
Psychemedics Corporation PMD	752 K	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	622 K	$ 25.97	-4.52 %	$ 33.7 M	USA
CareDx, Inc CDNA	9.99 M	$ 16.78	-3.95 %	$ 894 M	USA
Quotient Limited QTNT	4.66 M	-	-11.32 %	$ 1.1 M	Schweiz
Syneos Health SYNH	108 M	-	-	$ 4.46 B	USA